Register to chat with like-minded investors on our interactive forums.
Period:
Draw Mode:
| Volume | 4,701 |
|
|||||
| News | - | ||||||
| Day High | 1.7973 | Low High |
|||||
| Day Low | 1.7301 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Sonnet BioTherapeutics Holdings Inc | SONN | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.01 | 0.57% | 1.77 | 12:03:11 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 1.76 | 1.7301 | 1.7973 | 1.76 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 41 | 4,701 | $ 1.75 | $ 8,236 | - | 1.08 - 26.40 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 12:15:22 | 50 | $ 1.75 | USD |
Sonnet BioTherapeutics Holdings Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 5.43M | 3.07M | - | 148k | -18.83M | -6.14 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Sonnet BioTherapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical SONN Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.77 | 1.89 | 1.66 | 1.78 | 13,836 | 0.00 | 0.00% |
| 1 Month | 1.97 | 2.10 | 1.65 | 1.88 | 21,105 | -0.20 | -10.15% |
| 3 Months | 1.46 | 2.3399 | 1.31 | 1.98 | 109,313 | 0.31 | 21.23% |
| 6 Months | 1.32 | 2.3399 | 1.08 | 1.78 | 83,312 | 0.45 | 34.09% |
| 1 Year | 5.72 | 26.40 | 1.08 | 10.16 | 1,275,567 | -3.95 | -69.06% |
| 3 Years | 656.04 | 840.84 | 1.08 | 151.46 | 2,926,509 | -654.27 | -99.73% |
| 5 Years | 1,915.76 | 4,989.60 | 1.08 | 329.72 | 2,610,668 | -1,913.99 | -99.91% |
Sonnet BioTherapeutics Description
| Sonnet BioTherapeutics Holdings Inc is a clinical-stage biopharmaceutical company. The company has developed FHAB (Fully Human Albumin Binding) technology which is well suited for drug development across a range of human disease areas, including in oncology, autoimmune, pathogenic, inflammatory, and hematological conditions. The firm's pipeline products include SON-080 (low-dose IL-6), SON-1210 (IL15- FHAB-IL12), SON-1010 (IL12-FHAB), and others. |
